Despite national guidelines and proven health benefits, vaccination rates for the human papillomavirus (HPV) remain far below those of other vaccines recommended for adolescents. HPV is the most common sexually transmitted infection in the U.S; it is responsible for about 25,000 new cancers each year. A series of three shots is recommended for all girls and boys at age 11-12, but significant barriers exist to starting and finishing this series. This Issue Brief examines some of the barriers and summarizes a successful, multipronged clinical intervention to improve vaccination rates
Background: The Human Papillomavirus (HPV) is a significant factor associated with the development o...
Although the Human Papillomavirus (HPV) vaccine has been approved and recommended by the FDA and oth...
Background: Despite continued public health efforts to increase human papillomavirus (HPV) vaccinati...
Despite national guidelines and proven health benefits, vaccination rates for the human papillomavir...
Human papillomavirus virus (HPV) is a sexually transmitted disease that can negatively affect both m...
BACKGROUND:Human papillomavirus (HPV) vaccination has been recommended in the United States for fema...
Abstract Introduction: Human Papillomavirus (HPV) causes 32,500 new cancers and roughly 14 million ...
Introduction: Current rates of the Human Papillomavirus (HPV) vaccine for adolescents are not yet op...
IMPORTANCESince licensure of the human papillomavirus (HPV) vaccine in 2006, HPV vaccine coverage am...
IntroductionInfection with human papillomavirus (HPV) is common and can progress to various types of...
The human papillomavirus (HPV) is a very common sexually transmitted infection that affects an estim...
This project was undertaken with Shainy Varghese, Ph.D., APRN, CPNP and Sonya Wade, DNSc, APRN, FNP-...
Background: Human papillomavirus (HPV) is a sexually transmitted infection that can lead to cancers ...
BackgroundThe human papillomavirus (HPV) vaccine was recommended in 2007 by the Advisory Committee o...
In the United States, human papillomavirus (HPV) vaccine has been recommended for females since 2006...
Background: The Human Papillomavirus (HPV) is a significant factor associated with the development o...
Although the Human Papillomavirus (HPV) vaccine has been approved and recommended by the FDA and oth...
Background: Despite continued public health efforts to increase human papillomavirus (HPV) vaccinati...
Despite national guidelines and proven health benefits, vaccination rates for the human papillomavir...
Human papillomavirus virus (HPV) is a sexually transmitted disease that can negatively affect both m...
BACKGROUND:Human papillomavirus (HPV) vaccination has been recommended in the United States for fema...
Abstract Introduction: Human Papillomavirus (HPV) causes 32,500 new cancers and roughly 14 million ...
Introduction: Current rates of the Human Papillomavirus (HPV) vaccine for adolescents are not yet op...
IMPORTANCESince licensure of the human papillomavirus (HPV) vaccine in 2006, HPV vaccine coverage am...
IntroductionInfection with human papillomavirus (HPV) is common and can progress to various types of...
The human papillomavirus (HPV) is a very common sexually transmitted infection that affects an estim...
This project was undertaken with Shainy Varghese, Ph.D., APRN, CPNP and Sonya Wade, DNSc, APRN, FNP-...
Background: Human papillomavirus (HPV) is a sexually transmitted infection that can lead to cancers ...
BackgroundThe human papillomavirus (HPV) vaccine was recommended in 2007 by the Advisory Committee o...
In the United States, human papillomavirus (HPV) vaccine has been recommended for females since 2006...
Background: The Human Papillomavirus (HPV) is a significant factor associated with the development o...
Although the Human Papillomavirus (HPV) vaccine has been approved and recommended by the FDA and oth...
Background: Despite continued public health efforts to increase human papillomavirus (HPV) vaccinati...